Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
annum, AzoneTSTM, compound, forseeable, leaseholder, lesser, occurrence, permanently, prepay, resolved
Removed:
accredited, adjustment, agent, amounting, anticipate, application, assumed, behalf, beneficial, beneficially, blocker, Certificate, ChoiceTel, collectively, conversion, convert, converted, dated, Designation, dividend, earned, exercisable, extinguishment, face, feature, February, holder, incremental, initially, iv, liquidation, longer, made, merger, notice, November, obligated, ownership, Platinum, preference, provision, redeemable, reduction, secure, stated, strategic, thirty, tooling, virtue, waive, written
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.1 Amended and Restated Certificate of Incorporation
- 3.2 Certificate of Designation, Preferences and Rights of Series C Preferred Stock
- 3.3 Certificate of Designation, Preferences and Rights of Series D Preferred Stock
- 10.2 Amended and Restated License Agreement
- 31.1 Certification of the Principal Executive Officer
- 31.2 Certification of the Principal Financial Officer
- 32.1 Certification of the Principal Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of the Principal Financial Officer Pursuant to 18 U.s.c. Section 1350
ECTE similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Echo Therapeutics, Inc. (the “Company”) for the quarter ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Patrick T. Mooney, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Patrick T. Mooney
Patrick T. Mooney, M.D.
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
August 9, 2012